Ceva has announced the launch of Duoflect, a new parasiticide that can be used to treat and prevent flea and tick infestations in cats and dogs and their environment.
Duoflect contains a new formulation of fipronil and s-methoprene, offers a 100 percent longer duration of action against fleas in cats and a 13 percent longer duration in dogs than the current market-leading fipronil combination.
Its duration of action against ticks, meanwhile, is 150 percent longer in cats and 50 percent longer in dogs, and is available in easy-to-use freestanding pipettes to facilitate administration and handling of the pet while ensuring no spillages.
To support the launch of the new product, Ceva has produced a range of marketing material, including client leaflets, which will be distributed via veterinary practices.
Nicki Glen, marketing project manager for Duoflect at Ceva Animal Health, said: "Duoflect's new strength formulation provides a longer duration of action than the market-leading fipronil combination, while its efficacy is proven through 13 recent laboratory and field trials."
With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.